Beth A. McCormick, Ph.D.

Professor and Chair, Department of Microbiology
University of Massachusetts Chan Medical School


Professor Beth A. McCormick is the Worcester Foundation Chair II in Biomedical Sciences and Professor and Chair of the Department of Microbiology at UMass Chan Medical School. She earned her B.A. from the University of New Hampshire in 1986 and completed her Ph.D. in Microbiology at the University of Rhode Island in 1990. She then pursued postdoctoral training at Harvard Medical School, where she advanced through the academic ranks to Associate Professor in Pediatric Gastroenterology and served as a Senior Microbiologist at Massachusetts General Hospital. During this period, she also directed the Mucosal Immunology Laboratory, establishing a nationally recognized program at the intersection of host–pathogen interactions, epithelial biology, and gastrointestinal mucosal immunity.

Recruited to UMass Chan in 2008, Professor McCormick was appointed Chair of the Department of Microbiology in 2023 following a national search. In 2014, she founded the Program in Microbiome Dynamics and the Center for Microbiome Research, creating a leading hub for interdisciplinary investigation into microbial influences on health and disease. She has authored more than 150 peer-reviewed publications in top- tier journals, serves on national and international scientific leadership boards, and has maintained continuous NIH funding for more than two decades.

Professor McCormick is a Fellow of both the American Society for Microbiology and the American Gastroenterological Association and currently serves as Editor-in-Chief of Gut Microbes, a premier journal in the field. She is also the scientific founder of Adiso Therapeutics, a biotechnology company advancing first-in-class therapeutics for inflammatory diseases, highlighting the translational impact and clinical relevance of her scientific contributions.

To learn more, visit the McCormick Lab website and Professor McCormick’s LinkedIn page.

Funded Research

These projects were made possible from Cure Alzheimer's Fund support.